The Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)

Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of duloxetine tablets sold by Breckenridge Pharmaceutical, Inc. are being recalled because they are apparently contaminated with a carcinogen in the nitrosamine family. Drug regulators consider nitrosamines as “high potency mutagenic carcinogens.”

Nitrosamine contamination has been a known problem in some medications since at least 2018. Drugmakers are required to limit the presence of nitrosamine impurities in drugs.

Unfortunately, it appears that Breckenridge Pharmaceuticals failed to live up to its drug safety obligations. You can read more about the recall on the FDA’s website here.

If you take duloxetine from Breckenridge Pharmaceuticals, you may have legal claims against the company. The Block Firm is investigating a potential class action against Breckenridge, which is an important tool for maintaining the integrity of the U.S. drug supply system. However, please do not stop taking your medication without consulting with your physician, who will be able to guide you about the risks and benefits of your specific medication regimen.

If you are interested in learning more, please contact the experienced class action attorneys at The Block Firm.

Contact Us

Let us help you

    By submitting an email you are not creating an attorney-client relationship, but your submission is confidential.